Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | MR Angiography | Case report

Immune globulin/methylprednisolone/plasma

Reversible encephalopathy syndrome, reversible cerebral vasoconstriction syndrome-like cerebral vasoconstriction syndrome and lack of efficacy: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Belgrado E, et al. Posterior Reversible Encephalopathy Syndrome in Guillain-Barre Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports. Frontiers in Neurology 13: 1-6, 6 Apr 2022. Available from: URL: http://www.frontiersin.org/Neurology Belgrado E, et al. Posterior Reversible Encephalopathy Syndrome in Guillain-Barre Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports. Frontiers in Neurology 13: 1-6, 6 Apr 2022. Available from: URL: http://​www.​frontiersin.​org/​Neurology
Metadata
Title
Immune globulin/methylprednisolone/plasma
Reversible encephalopathy syndrome, reversible cerebral vasoconstriction syndrome-like cerebral vasoconstriction syndrome and lack of efficacy: 2 case reports
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17946-9

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Cobimetinib

Case report

Heparin

Case report

Ustekinumab

Case report

Antineoplastics